Nanobiotix
Paris
About Nanobiotix
Nanobiotix SA develops nanomedicine programs for the treatment of cancer. The company provides NanoXray that offers a solution for cancer therapy based on a technology that is designed to allow destruction of cancer cells by inert particles. Its products include magnetic particles and laser activated nanoparticles for the treatment and diagnostic of cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $408.6M
- Funding stage: IPO
- Last round: Post-IPO Debt (Oct 2025)
- Ticker: epa:NANO
- Website: nanobiotix.com
- Phone: +33 1 40 26 04 70
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/nanobiotix-96120 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.